Loading...
CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
High-risk human papillomavirus (HPV) is a common cause of cervical cancer. HPV E6 oncoprotein promotes the degradation of host tumor suppressor gene p53, leading to the development of tumors. Therapeutic strategies that specifically target E6, which is constitutively expressed in tumors and is not p...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6341785/ https://ncbi.nlm.nih.gov/pubmed/30675284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9815 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|